These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22334268)

  • 61. Regulatory B Cells: Dark Horse in Pregnancy Immunotherapy?
    Guzman-Genuino RM; Hayball JD; Diener KR
    J Mol Biol; 2021 Jan; 433(1):166596. PubMed ID: 32693108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human-derived natural antibodies: biomarkers and potential therapeutics.
    Xu X; Ng SM; Hassouna E; Warrington A; Oh SH; Rodriguez M
    Future Neurol; 2015; 10(1):25-39. PubMed ID: 25678860
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thinking inside the box: how T cell inhibitory receptors signal.
    Haining WN
    Nat Med; 2012 Sep; 18(9):1338-9. PubMed ID: 22961161
    [No Abstract]   [Full Text] [Related]  

  • 64. [Update on regulatory B cells].
    Bouaziz JD; de Masson A; Le Buanec H; Bagot M; Bensussan A
    Med Sci (Paris); 2014; 30(8-9):721-4. PubMed ID: 25174741
    [No Abstract]   [Full Text] [Related]  

  • 65. CD5 enhances Th17-cell differentiation by regulating IFN-γ response and RORγt localization.
    McGuire DJ; Rowse AL; Li H; Peng BJ; Sestero CM; Cashman KS; De Sarno P; Raman C
    Eur J Immunol; 2014 Apr; 44(4):1137-42. PubMed ID: 24356888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The multiple faces of CD5.
    Burgueño-Bucio E; Mier-Aguilar CA; Soldevila G
    J Leukoc Biol; 2019 May; 105(5):891-904. PubMed ID: 30676652
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD5 as a Target for Immune-Based Therapies.
    Consuegra-Fernández M; Aranda F; Simões I; Orta M; Sarukhan A; Lozano F
    Crit Rev Immunol; 2015; 35(2):85-115. PubMed ID: 26351145
    [TBL] [Abstract][Full Text] [Related]  

  • 68. B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
    van den Hoogen LL; Bisoendial RJ
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614819
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies.
    Newman H; Teachey DT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune System Sex Differences May Bridge the Gap Between Sex and Gender in Fibromyalgia.
    Meester I; Rivera-Silva GF; González-Salazar F
    Front Neurosci; 2019; 13():1414. PubMed ID: 32009888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions.
    Fleischer LC; Spencer HT; Raikar SS
    J Hematol Oncol; 2019 Dec; 12(1):141. PubMed ID: 31884955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders.
    Hughes HK; Mills Ko E; Rose D; Ashwood P
    Front Cell Neurosci; 2018; 12():405. PubMed ID: 30483058
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.
    Raikar SS; Fleischer LC; Moot R; Fedanov A; Paik NY; Knight KA; Doering CB; Spencer HT
    Oncoimmunology; 2018; 7(3):e1407898. PubMed ID: 29399409
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biochemical assessments of thyroid profile, serum 25-hydroxycholecalciferol and cluster of differentiation 5 expression levels among children with autism.
    Desoky T; Hassan MH; Fayed HM; Sakhr HM
    Neuropsychiatr Dis Treat; 2017; 13():2397-2403. PubMed ID: 28979127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204.
    Domingues RG; Lago-Baldaia I; Pereira-Castro I; Fachini JM; Oliveira L; Drpic D; Lopes N; Henriques T; Neilson JR; Carmo AM; Moreira A
    Eur J Immunol; 2016 Jun; 46(6):1490-503. PubMed ID: 27005442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice.
    Saad F; Saintamand A; Cogné M; Denizot Y
    Oncotarget; 2015 Aug; 6(24):20302-11. PubMed ID: 25980500
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cellular signaling in sinecatechins-treated external genital and perianal warts: unraveling the mechanism of action of a botanical therapy.
    Nguyen HP; Doan HQ; Rady P; Tyring SK
    Virol Sin; 2015 Jun; 30(3):214-7. PubMed ID: 25822119
    [No Abstract]   [Full Text] [Related]  

  • 78. Basic science for the clinician 54: CD5.
    Sigal LH
    J Clin Rheumatol; 2012 Mar; 18(2):83-8. PubMed ID: 22334268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD5: a safeguard against autoimmunity and a shield for cancer cells.
    Dalloul A
    Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
    Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
    J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.